Radiation boost added to standard drugs in fight against spreading breast cancer
NCT ID NCT04563507
Summary
This study is testing whether adding targeted radiation to standard hormone therapy drugs helps control advanced breast cancer that has spread. It will enroll 102 women with hormone-positive breast cancer that has metastasized to up to five sites. Researchers want to see if this combination approach keeps the cancer from progressing longer than standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brooklyn Methodist Hospital - NewYork Presbyterian
RECRUITINGNew York, New York, 11215, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
New York Presbyterian Hospital - Queens
RECRUITINGNew York, New York, 11355, United States
Contact
Contact Email: •••••@•••••
Contact
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.